Treatment of immune checkpoint inhibitor-induced bullous pemphigoid with methotrexate.
作者信息
Myers Emma L, Googe Paul B, Culton Donna A
机构信息
University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Dermatopathology Laboratory, Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
出版信息
JAAD Case Rep. 2024 Oct 11;54:31-36. doi: 10.1016/j.jdcr.2024.09.019. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Treatment of immune checkpoint inhibitor-induced bullous pemphigoid with methotrexate.甲氨蝶呤治疗免疫检查点抑制剂诱导的大疱性类天疱疮
JAAD Case Rep. 2024 Oct 11;54:31-36. doi: 10.1016/j.jdcr.2024.09.019. eCollection 2024 Dec.
2
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid.甲氨蝶呤治疗免疫检查点抑制剂诱导的大疱性类天疱疮。
Eur J Cancer. 2021 Dec;159:34-37. doi: 10.1016/j.ejca.2021.09.032. Epub 2021 Oct 30.
3
A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation.一例继发于检查点抑制剂免疫治疗的大疱性类天疱疮罕见病例：情况危急
Cureus. 2021 Jul 4;13(7):e16169. doi: 10.7759/cureus.16169. eCollection 2021 Jul.
4
A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report.一例继发于免疫治疗的药物性大疱性类天疱疮，使用乌帕替尼治疗：病例报告。
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160926. doi: 10.1177/2050313X231160926. eCollection 2023.
5
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.转移性肾细胞癌患者停用免疫检查点抑制剂后疾病持久控制且并发难治性大疱性类天疱疮：一例报告。
Front Immunol. 2022 Sep 16;13:984132. doi: 10.3389/fimmu.2022.984132. eCollection 2022.
6
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.大疱性类天疱疮作为免疫检查点抑制剂不良反应的单机构回顾性研究经验
Cancers (Basel). 2022 Nov 5;14(21):5451. doi: 10.3390/cancers14215451.
7
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.免疫检查点抑制剂相关的大疱性皮肤免疫相关不良事件：一项多中心观察性研究。
Br J Dermatol. 2022 Dec;187(6):981-987. doi: 10.1111/bjd.21836. Epub 2022 Sep 6.
8
Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab.纳武单抗继发大疱性类天疱疮的延迟发作
Cureus. 2023 Aug 9;15(8):e43230. doi: 10.7759/cureus.43230. eCollection 2023 Aug.
9
Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.与抗程序性细胞死亡蛋白1和抗程序性细胞死亡配体1治疗相关的大疱性类天疱疮：文献综述
Acta Derm Venereol. 2021 Jan 20;101(1):adv00377. doi: 10.2340/00015555-3740.
10
Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.老年女性非小细胞肺癌患者应用帕博利珠单抗治疗后发生大疱性类天疱疮：病例报告及文献复习。
J Oncol Pharm Pract. 2021 Apr;27(3):727-733. doi: 10.1177/1078155220946370. Epub 2020 Aug 9.
引用本文的文献
1
A Narrative Review of Pemphigoid Diseases: Bridging Associations, Comorbidities, and Management.类天疱疮疾病的叙述性综述：关联、合并症与管理之间的桥梁
Dermatol Ther (Heidelb). 2025 May 24. doi: 10.1007/s13555-025-01444-9.
Zotero 插件